The March, 2026, decision by the French drug regulatory agency to approve intravenous racemic ketamine for the treatment of adult severe suicidal crisis1 represents a major step forward in the ...
A WOMAN with more than 40 allergies has told how a life-changing NHS jab has helped cure them all. Chloe Ramsey, from Liss in ...
EU grants marketing approval to ALK’s EURneffy 1 mg, a needle-free adrenaline treatment for young children at risk of anaphylaxis: Denmark Thursday, April 2, 2026, 13:00 Hrs [IS ...
The ability to avoid routine needle carrying skyrocketed the value-based price (VBP) of nasal epinephrine to more than 1200% above baseline, according to new modeling data presented at the annual ...
Today, ALK announced that children aged 4 and older living with severe allergies across the EU can now access the first and only needle-free adrenaline treatment for anaphylaxis, after the European ...
House Bill 533 and Senate Bill 351 would allow any FDA-approved epinephrine in Alabama schools, including needle-free options ...
Children were previously required to weigh ≥33 lbs. and <66 lbs. and be at least four years of age to receive neffy 1 mg dose - approval ...
Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.
Aspire Allergy & Sinus Dr. Haley Overstreet highlights new research on needle-free treatment for severe allergic reactions. Epinephrine saves lives—but too often, hesitation gets in the way. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results